PURPOSE: To evaluate the best strategy for treatment of sarcoma that occurs after radiation
therapy. MATERIALS AND METHODS: Records were retrospectively reviewed for 80 …

Background Since 2010, nationwide networks of reference centers for sarcomas (RREPS/NETSARC/RESOS)
collected and prospectively reviewed all cases of sarcomas and …

Background Advances in molecular genetics of sarcoma have enabled the identification of
type-specific aberrations. We aimed to assess the clinical effect of systematic implementation …

Inflammatory malignant fibrous histiocytoma (inflammatory MFH) is a very rare tumour that
occurs most often in the retroperitoneum. So far, it has been considered to be a special …

Expression of hormone receptor (HR) for estrogens (ER) and progesterone (PR) and HER2
remains the cornerstone to define the therapeutic strategy for breast cancer patients. We …

We evaluated the predictive value of a tumor’s HER-2 status for chemotherapy response in
the neoadjuvant setting and the effect of anthracycline dose intensity on this predictive value. …

The last international guidelines on HER2 determination in breast cancer have been
updated in 2018 by the American Society of Clinical Oncology and College of American …

Despite a growing incidence in developed countries and a recent improved understanding
of its pathogenesis, anal cancer management has not evolved over the past decades and …

The accurate determination of HER-2 in invasive breast cancer has become a critical issue,
particularly in the context of the results of recent trastuzumab (Herceptin ® ) adjuvant trials. …

The transforming potential of the MDM2 oncogene has been attributed to the overproduction
of the protein. In order to investigate regulation of MDM2 expression in head and neck …